Skip to main content
NCBI home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1988 Mar;25(3):315–321. doi: 10.1111/j.1365-2125.1988.tb03309.x

The effect of acute and chronic captopril therapy on baroreflex function in man.

G B Kondowe 1, A H Deering 1, J G Riddell 1, G D Johnston 1, D W Harron 1
PMCID: PMC1386355  PMID: 3129008

Abstract

1. The effect of captopril 12.5 mg three times daily for 14 days on baroreflex sensitivity was investigated in six normotensive salt-replete male subjects. 2. Baroreflex sensitivity [delta R-R interval ms/mmHg systolic blood pressure (SBP)] was assessed following decreases and increases in SBP with glyceryl trinitrate and phenylephrine respectively and during Valsalva's manoeuvre. 3. Captopril had no effect on supine intra-arterial SBP or R-R interval on days 1 and 15 compared with placebo. However decreases (P less than 0.05) which occurred in plasma angiotensin II on day 1 (12.3 +/- 0.8 to 7.6 +/- 1.5 pg ml-1) and on day 15 (14.5 +/- 1.5 to 6.3 +/- 0.5 pg ml-1) and increases (P less than 0.02) in plasma renin activity on day 1 (1.2 +/- 0.7 to 4.8 +/- 0.8 ng A I ml-1 h-1) and on day 15 (1.1 +/- 0.2 to 5.4 +/- 0.9 ng A I ml-1 h-1) compared with placebo, indicated angiotensin-converting enzyme inhibition. 4. Baroreflex sensitivity was unchanged by captopril on day 1 and day 15 compared with placebo following the use of glyceryl trinitrate and phenylephrine to deactivate and activate respectively the baroreceptors, and during the strain and release phases of Valsalva's manoeuvre.

Full text

PDF
315

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ajayi A. A., Campbell B. C., Meredith P. A., Kelman A. W., Reid J. L. The effect of captopril on the reflex control heart rate: possible mechanisms. Br J Clin Pharmacol. 1985 Jul;20(1):17–25. doi: 10.1111/j.1365-2125.1985.tb02793.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Ajayi A. A., Reid J. L. The effect of enalapril on baroreceptor mediated reflex function in normotensive subjects. Br J Clin Pharmacol. 1986 Mar;21(3):338–339. doi: 10.1111/j.1365-2125.1986.tb05203.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bristow J. D., Honour A. J., Pickering G. W., Sleight P., Smyth H. S. Diminished baroreflex sensitivity in high blood pressure. Circulation. 1969 Jan;39(1):48–54. doi: 10.1161/01.cir.39.1.48. [DOI] [PubMed] [Google Scholar]
  4. Campbell B. C., Shepherd A. N., Reid J. L. Effects of the angiotensin converting enzyme inhibitor, captopril, in essential hypertension. Br J Clin Pharmacol. 1982 Feb;13(2):213–217. doi: 10.1111/j.1365-2125.1982.tb01359.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Campbell B. C., Sturani A., Reid J. L. Evidence of parasympathetic activity of the angiotensin converting enzyme inhibitor, captopril, in normotensive man. Clin Sci (Lond) 1985 Jan;68(1):49–56. doi: 10.1042/cs0680049. [DOI] [PubMed] [Google Scholar]
  6. Case D. B., Atlas S. A., Laragh J. H., Sealey J. E., Sullivan P. A., McKinstry D. N. Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients. Prog Cardiovasc Dis. 1978 Nov-Dec;21(3):195–206. doi: 10.1016/0033-0620(78)90025-7. [DOI] [PubMed] [Google Scholar]
  7. Cody R. J., Jr, Tarazi R. C., Bravo E. L., Fouad F. M. Haemodynamics of orally-active converting enzyme inhibitor (SQ 14225) in hypertensive patients. Clin Sci Mol Med. 1978 Nov;55(5):453–459. doi: 10.1042/cs0550453. [DOI] [PubMed] [Google Scholar]
  8. Collis M. G., Keddie J. R. Captopril attenuates adrenergic vasoconstriction in rat mesenteric arteries by angiotensin-dependent and -independent mechanisms. Clin Sci (Lond) 1981 Sep;61(3):281–286. doi: 10.1042/cs0610281. [DOI] [PubMed] [Google Scholar]
  9. DEPASQUALE N. P., BURCH G. E. EFFECT OF ANGIOTENSIN II ON THE INTACT FOREARM VEINS OF MAN. Circ Res. 1963 Sep;13:239–245. doi: 10.1161/01.res.13.3.239. [DOI] [PubMed] [Google Scholar]
  10. Ebert T. J. Captopril potentiates chronotropic baroreflex responses to carotid stimuli in humans. Hypertension. 1985 Jul-Aug;7(4):602–606. doi: 10.1161/01.hyp.7.4.602. [DOI] [PubMed] [Google Scholar]
  11. Ferguson R. K., Turini G. A., Brunner H. R., Gavras H., McKinstry D. N. A specific orally active inhibitor of angiotensin-converting enzyme in man. Lancet. 1977 Apr 9;1(8015):775–778. doi: 10.1016/s0140-6736(77)92958-0. [DOI] [PubMed] [Google Scholar]
  12. Fruncillo R. J., Rotmensch H. H., Vlasses P. H., Koplin J. R., Swanson B. N., Ferguson R. K. Effect of captopril and hydrochlorothiazide on the response to pressor agents in hypertensives. Eur J Clin Pharmacol. 1985;28(1):5–9. doi: 10.1007/BF00635700. [DOI] [PubMed] [Google Scholar]
  13. Goldstein D. S., Horwitz D., Keiser H. R. Comparison of techniques for measuring baroreflex sensitivity in man. Circulation. 1982 Aug;66(2):432–439. doi: 10.1161/01.cir.66.2.432. [DOI] [PubMed] [Google Scholar]
  14. Haber E., Koerner T., Page L. B., Kliman B., Purnode A. Application of a radioimmunoassay for angiotensin I to the physiologic measurements of plasma renin activity in normal human subjects. J Clin Endocrinol Metab. 1969 Oct;29(10):1349–1355. doi: 10.1210/jcem-29-10-1349. [DOI] [PubMed] [Google Scholar]
  15. Harron D. W., Riddell J. G., Shanks R. G. Effects of azepexole and clonidine on baroreceptor mediated reflex bradycardia and physiological tremor in man. Br J Clin Pharmacol. 1985 Nov;20(5):431–436. doi: 10.1111/j.1365-2125.1985.tb05093.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. Hatton R., Clough D., Faulkner K., Conway J. Angiotensin-converting enzyme inhibitor resets baroreceptor reflexes in conscious dogs. Hypertension. 1981 Nov-Dec;3(6):676–681. doi: 10.1161/01.hyp.3.6.676. [DOI] [PubMed] [Google Scholar]
  17. Heavey D. J., Reid J. L. The effect of SQ 14225 on baroreceptor reflex sensitivity in conscious normotensive rabbits [proceedings]. Br J Pharmacol. 1978 Nov;64(3):389P–390P. [PMC free article] [PubMed] [Google Scholar]
  18. Imai Y., Abe K., Seino M., Haruyama T., Tajima J., Sato M., Goto T., Hiwatari M., Kasai Y., Yoshinaga K. Attenuation of pressor responses to norepinephrine and pitressin and potentiation of pressor response to angiotensin II by captopril in human subjects. Hypertension. 1982 May-Jun;4(3):444–451. doi: 10.1161/01.hyp.4.3.444. [DOI] [PubMed] [Google Scholar]
  19. Lumbers E. R., McCloskey D. I., Potter E. K. Inhibition by angiotensin II of baroreceptor-evoked activity in cardiac vagal efferent nerves in the dog. J Physiol. 1979 Sep;294:69–80. doi: 10.1113/jphysiol.1979.sp012915. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Mancia G., Ferrari A., Gregorini L., Valentini R., Ludbrook J., Zanchetti A. Circulatory reflexes from carotid and extracarotid baroreceptor areas in man. Circ Res. 1977 Sep;41(3):309–315. doi: 10.1161/01.res.41.3.309. [DOI] [PubMed] [Google Scholar]
  21. Mancia G., Parati G., Pomidossi G., Grassi G., Bertinieri G., Buccino N., Ferrari A., Gregorini L., Rupoli L., Zanchetti A. Modification of arterial baroreflexes by captopril in essential hypertension. Am J Cardiol. 1982 Apr 21;49(6):1415–1419. doi: 10.1016/0002-9149(82)90353-8. [DOI] [PubMed] [Google Scholar]
  22. Marks E. S., Bing R. F., Thurston H., Swales J. D. Vasodepressor property of the converting enzyme inhibitor captopril (SQ 14 225): the role of factors other than renin-angiotensin blockade in the rat. Clin Sci (Lond) 1980 Jan;58(1):1–6. doi: 10.1042/cs0580001. [DOI] [PubMed] [Google Scholar]
  23. Millar J. A., Derkx F. H., McLean K., Reid J. L. Pharmacodynamics of converting enzyme inhibition: the cardiovascular, endocrine and autonomic effects of MK421 (enalapril) and MK521. Br J Clin Pharmacol. 1982 Sep;14(3):347–355. doi: 10.1111/j.1365-2125.1982.tb01990.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  24. Nussberger J., Re R., Matsueda G. R., Haber E. A simplified radioimmunoassay for physiologically active angiotensin peptides [(1-8) octa- and (2-8) heptapeptides]. Horm Metab Res. 1984 Nov;16(11):606–610. doi: 10.1055/s-2007-1014862. [DOI] [PubMed] [Google Scholar]
  25. Potter E. K. Angiotensin inhibits action of vagus nerve at the heart. Br J Pharmacol. 1982 Jan;75(1):9–11. doi: 10.1111/j.1476-5381.1982.tb08752.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Richer C., Doussau M. P., Giudicelli J. F. Effects of captopril and enalapril on regional vascular resistance and reactivity in spontaneously hypertensive rats. Hypertension. 1983 May-Jun;5(3):312–320. doi: 10.1161/01.hyp.5.3.312. [DOI] [PubMed] [Google Scholar]
  27. Smyth H. S., Sleight P., Pickering G. W. Reflex regulation of arterial pressure during sleep in man. A quantitative method of assessing baroreflex sensitivity. Circ Res. 1969 Jan;24(1):109–121. doi: 10.1161/01.res.24.1.109. [DOI] [PubMed] [Google Scholar]
  28. Warren S. E., O'Connor D. T., Cohen I. M. Autonomic and baroreflex function after captopril in hypertension. Am Heart J. 1983 Jun;105(6):1002–1008. doi: 10.1016/0002-8703(83)90403-9. [DOI] [PubMed] [Google Scholar]
  29. Zanella M. T., Bravo E. L., Fouad F. M., Tarazi R. C. Long-term converting enzyme inhibition and sympathetic nerve function in hypertensive humans. Hypertension. 1981 Nov-Dec;3(6 Pt 2):II–216-21. doi: 10.1161/01.hyp.3.6_pt_2.ii-216. [DOI] [PubMed] [Google Scholar]
  30. Zimmerman B. G. Adrenergic facilitation by angiotensin: does it serve a physiological function? Clin Sci (Lond) 1981 Apr;60(4):343–348. doi: 10.1042/cs0600343. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES